Breaking News Instant updates and real-time market news.

KHC

Kraft Heinz

$96.57

9.29 (10.64%)

, UN

Unilever; also tag UL

$48.79

6.47 (15.29%)

16:33
02/17/17
02/17
16:33
02/17/17
16:33

On The Fly: Stocks end week higher amid signals of rate hike, tax reform

Stocks ended the week higher following Federal Reserve Chair Janet Yellen's flagging of a possible interest rate rise next month and as President Donald Trump talked up plans for upcoming tax reform. MACRO NEWS: In the U.S., the Producer Price Index rose 0.6% in January, with the core rate up 0.4%. The Consumer Price Index increased 0.6% in January. The core CPI reading, which removes food and energy, rose 0.3%. Retail sales were up 0.4% last month. When autos and gas are removed, the core reading was up 0.7%. Industrial production slipped 0.3% in January, with capacity at 75.3%. The February Empire State manufacturing index rose to 18.7. Initial jobless claims rose 5,000 to 239,000 in the week ended February 11. Housing starts fell 2.6% to a 1.246M rate in January, while building permits rose 4.6% to a 1.285M rate. The Philly Fed business outlook survey surged 19.7 points to a reading of 43.3. The leading economic indicators rose 0.6% to 125.5 in January... During her semiannual monetary policy report to the Congress, Fed Chair Janet Yellen said it is "unwise" to wait too long to raise rates as it could require the FOMC to "eventually raise rates rapidly, which could risk disrupting financial markets and pushing the economy into recession." The economic outlook is uncertain, and "monetary policy is not on a preset course," she added... In Asia, Japan's fourth quarter GDP growth of 1% was about in-line with the consensus forecast for growth of 1.1%. China's Consumer Price Index rose 2.5% on the year in January, while its Producer Price Index rose 0.6%... In Europe, the European Commission raised its growth forecasts for 2017 to 1.6% from 1.5% and for 2018 to 1.8% from 1.7%. Fourth quarter Eurozone GDP flash came in at 0.4%, while Eurozone Industrial Production fell 1.6% in December. COMPANY NEWS: Kraft Heinz (KHC) confirmed that it has made a comprehensive proposal to Unilever (UN; UL) about combining the two groups. However, the latter has rejected the $143B offer saying that it "fundamentally undervalues" the company... Verizon (VZ) announced that will start selling unlimited data plans. Later in the week, AT&T (T) announced that it will launch its own new Unlimited plan, available to all consumer and business postpaid AT&T wireless customers. Against that backdrop of a new front in the pricing war among wireless service providers, Reuters said on Friday that SoftBank (SFTBF) is prepared to relinquish control of Sprint (S) to Deutsche Telekom's (DTEGY) T-Mobile US (TMUS) to clinch a tie-up of the two U.S. carriers. The Japanese company has not yet approached Deutsche Telekom to talk about any deal because the U.S. Federal Communications Commission has established strict anti-collusion rules that prohibit talks between rivals during the ongoing auction of airwaves, the report added... In other M&A news, in a week full of deal headlines, Allergan (AGN) announced that it is acquiring Zeltiq Aesthetics (ZLTQ) for $2.475B, or $56.50 per share. Hologic (HOLX) announced a definitive agreement to acquire all outstanding Cynosure (CYNO) shares for $66.00 per share in cash, which corresponds to an equity value of approximately $1.65B and an enterprise value of $1.44B net of cash. Fortress Investment Group (FIG) agreed to be acquired by Japan's SoftBank for roughly $3.3B in cash. Integrated Device Technology (IDTI) agreed to acquire GigPeak (GIG) for total cash consideration of $3.08 per share, or approximately $250M in cash. According to a report by Reuters, Restaurant Brands (QSR), the owner of Burger King and Tim Horton's, approached Popeyes Louisiana Kitchen (PLKI) to show interest in a potential takeover. Verizon and Yahoo (YHOO) are said to have tentatively reached a new merger pact under which Verizon will pay $250M less to acquire Yahoo. In addition, both companies will reportedly share in the legal responsibility from recent hacking incidents as part of the new pact. Kate Spade (KATE) pre-reported quarterly results and announced a strategic process, confirming media reports in recent months of a potential sale... Aetna (AET) and Humana (HUM) mutually ended their merger agreement following a ruling from the U.S. District Court for the District of Columbia granting a Department of Justice request to enjoin the deal. Under the terms of the merger agreement, Humana is entitled to a breakup fee of $1B, or approximately $630M, net of tax. Cigna (CI) also announced it is terminating the proposed merger agreement with Anthem (ANTM) following the order from the U.S. District Court for the District of Columbia enjoining the transaction. To effect this termination, Cigna has filed suit against Anthem, seeking payment by Anthem of the $1.85B reverse termination fee contemplated in the merger agreement, as well as additional damages in an amount exceeding $13B. However, Anthem announced that it has filed its own lawsuit in Delaware seeking a temporary restraining order to enjoin Cigna from terminating, and taking any action contrary to the terms of, their merger agreement, contending that Cigna does not have a right to terminate the pact... Dow member UnitedHealth (UNH) fell more than 4% on Friday following reports it was the subject of an investigation by the DOJ for Medicare fraud. Volkswagen (VLKAY) and Mobileye (MBLY) reached a pact over new navigation standard for autonomous driving, with future Volkswagen models using the camera-based map and localization technology Road Experience Management from Mobileye... Chemours (CC) announced an agreement with DuPont (DD) to address the costs of the global settlement of the multi-district PFOA litigation between DuPont and the plaintiffs... Hain Celestial (HAIN) disclosed that it received a subpoena from the SEC over its accounting... Among companies that announced quarterly results this week, Cisco Systems (CSCO), Deere (DE), Teva Pharmaceutical (TEVA), Chegg (CHGG), Groupon (GRPN), Wix.com (WIX), NetApp (NTAP), TrueCar (TRUE), and Arista Networks (ANET) advanced following their reports, while PepsiCo (PEP), Snyder's-Lance (LNCE), AIG (AIG), Fossil Group (FOSL), LendingClub (LC), Kraft Heinz, GNC (GNC), MGM Resorts (MGM), Molina Healthcare (MOH), J M Smucker (SJM), and Campbell Soup (CPB) declined. INDEXES: For the week, the Dow rose 1.73% to 20,624.05, the Nasdaq advanced 1.8% to 5,838.58, and the S&P 500 gained 1.49% to 2,351.16.

KHC

Kraft Heinz

$96.57

9.29 (10.64%)

UN

Unilever; also tag UL

$48.79

6.47 (15.29%)

UL

Unilever; also tag UN

$48.53

5.96 (14.00%)

VZ

Verizon

$49.19

0.73 (1.51%)

S

Sprint

$9.30

0.3 (3.33%)

T

AT&T

$41.48

0.23 (0.56%)

TMUS

T-Mobile

$63.92

3.31 (5.46%)

UNH

UnitedHealth

$157.62

-6.03 (-3.68%)

AET

Aetna

$125.27

-4.22 (-3.26%)

HUM

Humana

$204.60

-4.14 (-1.98%)

CI

Cigna

$143.56

-1.77 (-1.22%)

ANTM

Anthem

$160.25

-3.52 (-2.15%)

YHOO

Tag AABA

$45.10

-0.06 (-0.13%)

VLKAY

Volkswagen

$30.87

-0.65 (-2.06%)

MBLY

Mobileye

$45.65

0.68 (1.51%)

CC

Chemours

$33.06

1.16 (3.64%)

DD

Changed to DWDP

$77.49

-0.3 (-0.39%)

HAIN

Hain Celestial

$34.95

0.49 (1.42%)

KATE

Kate Spade

$23.19

0.63 (2.79%)

AGN

Allergan

$247.35

0.42 (0.17%)

ZLTQ

ZELTIQ

$55.67

-0.02 (-0.04%)

QSR

Restaurant Brands

$53.90

0.05 (0.09%)

PLKI

Acquired by QSR

$66.12

-0.26 (-0.39%)

HOLX

Hologic

$40.00

0.47 (1.19%)

CYNO

Cynosure

$66.25

0.275 (0.42%)

IDTI

Integrated Device

$24.42

-0.15 (-0.61%)

GIG

GigPeak

$3.06

0.01 (0.33%)

FIG

Fortress

$7.99

0.02 (0.25%)

SFTBF

SoftBank

$76.00

0.248 (0.33%)

TEVA

Teva

$35.20

-0.61 (-1.70%)

CHGG

Chegg

$8.04

0.01 (0.12%)

GRPN

Groupon

$4.66

0.03 (0.65%)

WIX

Wix.com

$63.85

0.9 (1.43%)

CSCO

Cisco

$33.72

0.12 (0.36%)

NTAP

NetApp

$40.17

-0.39 (-0.96%)

DE

Deere

$110.27

1.1 (1.01%)

TRUE

TrueCar

$14.38

1.13 (8.53%)

ANET

Arista Networks

$119.06

18.89 (18.86%)

LNCE

Snyder's-Lance

$39.00

-0.34 (-0.86%)

AIG

AIG

$62.50

0.23 (0.37%)

PEP

PepsiCo

$108.15

0.03 (0.03%)

FOSL

Fossil

$20.73

0.49 (2.42%)

LC

LendingClub

$5.63

-0.15 (-2.60%)

GNC

GNC Holdings

$7.64

-0.08 (-1.04%)

MGM

MGM Resorts

$26.60

-0.26 (-0.97%)

MOH

Molina Healthcare

$48.23

-0.95 (-1.93%)

SJM

J.M. Smucker

$135.95

-1.89 (-1.37%)

CPB

Campbell Soup

$58.48

-4.07 (-6.51%)

  • 17

    Feb

  • 17

    Feb

  • 17

    Feb

  • 17

    Feb

  • 17

    Feb

  • 19

    Feb

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 01

    Mar

  • 02

    Mar

  • 03

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 09

    Mar

  • 13

    Mar

  • 14

    Mar

  • 14

    Mar

  • 19

    Mar

  • 27

    Mar

  • 04

    Apr

  • 05

    Apr

  • 25

    Apr

  • 04

    May

KHC Kraft Heinz
$96.57

9.29 (10.64%)

02/15/17
DBAB
02/15/17
INITIATION
Target $103
DBAB
Buy
Kraft Heinz initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Rob Dickerson started Kraft Heinz with a Buy rating and $103 price target.
02/16/17
SUSQ
02/16/17
DOWNGRADE
SUSQ
Neutral
Kraft Heinz downgraded to Neutral from Positive at Susquehanna
02/17/17
RBCM
02/17/17
NO CHANGE
Target $105
RBCM
Outperform
Edgewell Personal Care remains takeout target, says RBC Capital
After Kraft Heinz (KHC) confirmed it had approached Unilever (UN, UL) with a merger proposal, RBC Capital analyst Nik Modi says the news come as a surprise, but does not warrant a change in his Edgewell Personal Care (EPC) takeout thesis. The analyst reiterates an Outperform rating on the latter's shares, with a $105 price target, on improving margin and revenue profile and the prospects of a takeout in the next 12-16 months, with Unilever as one of the more likely buyers. Other potential suitors include Kimberly-Clark (KMB), Beiersdorf, Henkel, Johnson & Johnson (JNJ), Colgate-Palmolive (CL), Church & Dwight (CHD), L'Oreal (LRLCY), and Kao, he adds.
02/15/17
02/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Kraft Heinz (KHC) and ConAgra Brands (CAG) were initiated with Buy ratings at Deutsche Bank. The firm also initiated Campbell Soup (CPB), J.M. Smucker (SJM) General Mills (GIS), Hershey (HSY), Kellogg (K) and Mondelez (MDLZ) with a Hold, as well as Pinnacle Foods (PF), Hostess Brands (TWNK) and Snyder's Lance (LNCE) with a Buy. 2. MasterCard (MA) and Visa (V) initiated with Buy ratings at Loop Capital by analyst Joseph Vafi. 3. Bioverativ (BIVV) initiated with an Outperform rating and $56 price target at Leerink by analyst Jason Gerberry. 4. Encana (ECA) initiated with an Overweight at JPMorgan. The firm also reinstated Cheniere Energy (LNG) and Cheniere Energy Partners LP (CQH) with Overweight ratings. 5. Blueprint Medicines (BPMC) initiated with an Overweight at Morgan Stanley by analyst Andrew Berens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here
UN Unilever; also tag UL
$48.79

6.47 (15.29%)

01/23/17
LEHM
01/23/17
DOWNGRADE
LEHM
Equal Weight
Unilever downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Simon Hales downgraded Unilever to Equal Weight citing recent sector outperformance, currency uncertainty, and rising oil related input costs.
12/13/16
JEFF
12/13/16
UPGRADE
JEFF
Buy
Unilever upgraded to Buy from Hold at Jefferies
Jefferies analyst Martin Deboo upgraded Unilever to Buy and raised his price target for the shares to EUR 44 from EUR 40.
01/23/17
01/23/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Verizon (VZ) downgraded to Market Perform from Outperform at Wells Fargo with analyst Jennifer Fritzsche saying the stock's outperformance since U.S. presidential election is not sustainable given growth headwinds in 2017. 2. Qualcomm (QCOM) downgraded to Neutral from Buy at Nomura and to Underperform from Buy at CLSA. 3. Schlumberger (SLB) downgraded to Equal Weight from Overweight at Stephens with analyst Matthew Marietta saying he remains confident in Schlumberger's ability to benefit from the Cameron (CAM) integration, and its wide-ranging suite of products/services. 4. Unilever (UL, UN) downgraded to Equal Weight from Overweight at Barclays with analyst Simon Hales citing recent sector outperformance, currency uncertainty, and rising oil related input costs. 5. Kansas City Southern (KSU) downgraded to Neutral from Accumulate at Seaport Global with analyst Mark Levin saying there is too much uncertainty around U.S./Mexico trade policy to accurately forecast what earnings will look like in 2019 and beyond. The analyst acknowledges shares are "cheap" and maintained his $90 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
UL Unilever; also tag UN
$48.53

5.96 (14.00%)

VZ Verizon
$49.19

0.73 (1.51%)

02/17/17
02/17/17
DOWNGRADE
Target $345

Market Perform
Charter downgraded to Market Perform after recent rally at Telsey Advisory
As previously reported, Telsey Advisory analyst Tom Eagan downgraded Charter (CHTR) to Market Perform from Outperform, stating that he has "no doubt" that the company will improve the service metrics at the legacy TWC and Bright House systems, but that shares have gained more than 54% since January 2016, with part of the rise fueled by speculation that Verizon (VZ) was interested in an acquisition. While unclear what Verizon's real interest is, "the possibility of a transaction is not grounds" for a multiple on Charter shares that would yield a target in the mid-$370's, Eagen tells investors. He did, though, raise his price target on Charter shares to $345 from $308.
01/31/17
01/31/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. T-Mobile (TMUS) was initiated with a Buy at Evercore ISI, while Sprint (S), Verizon (VZ), and AT&T (T) were initiated with a Hold. 2. ViaSat (VSAT) initiated with an Outperform at William Blair. 3. Wyndham (WYN) initiated with a Neutral at Janney Capital. 4. ILG (ILG) initiated with a Buy at Janney Capital. 5. United Natural Foods (UNFI) initiated with a Neutral at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/09/17
MSCO
02/09/17
NO CHANGE
Target $10
MSCO
Underweight
Morgan Stanley cuts Twitter price target to $10
Morgan Stanley analyst Brian Nowak cut his price target for Twitter (TWTR) shares to $10 from $13.50 following this morning's Q4 earnings report. The stock is down 11%, or $1.99, to $16.73 in afternoon trading. Twitter's results and guidance were weaker than expected, and advertising revenue is now expected to fall by 15% in 2017, Nowak tells investors in a post-earnings research note. His new price target implies eight times his 2018 EBITDA estimate. This is appropriate as Yahoo and AOL were sold to Verizon (VZ) at between five and eight times EBITDA, the analyst contends. He keeps an Underweight rating on Twitter. Increasing competition for digital advertising dollars, which the company noted started in January, along with falling overall time spent per U.S. mobile user speaks to the company's challenges ahead, Nowak writes.
02/03/17
OPCO
02/03/17
NO CHANGE
OPCO
Content/application acquisitions more likely for Verizon, says Oppenheimer
Oppenheimer analyst Timothy Horan says that while he does see a merger with Charter (CHTR) and especially with Comcast (CMCSA) working financially, he believes Verizon (VZ) has its sights set on becoming a platform for digital content/apps monetized with programmatic advertising. This, combined with using wireless technologies to replace wireline broadband, could be "very disruptive to the cable industry," he adds. The analyst sees further acquisitions of content/application companies as more likely for Verizon.
S Sprint
$9.30

0.3 (3.33%)

01/26/17
OPCO
01/26/17
NO CHANGE
OPCO
Verizon deal for Charter would make strategic sense, says Oppenheimer
Following multiple media reports indicating that Verizon (VZ) is exploring the potential for a combination with Charter Communications (CHTR), Oppenheimer analyst Timothy Horan said such a deal would make strategic sense as owning a cable company would allow Verizon to bundle wireless and wireline to create a "lower-cost and better" 5G offering. Valuation would be a major sticking point, however, Horan tells investors. If such a deal were to happen, it would be "very positive" for T-Mobile (TMUS) as it would make a theoretical deal with Sprint (S) easier to get done or it could make Comcast (CMCSA) more likely to look at a takeover of the wireless company, added the analyst. However, DISH's (DISH) strategic options may be more limited following a Verizon-Charter tie-up, Horan added.
01/30/17
EVER
01/30/17
INITIATION
Target $8
EVER
Hold
Sprint initiated with a Hold at Evercore ISI
Evercore ISI analyst Vijay Jayant started Sprint with a Hold rating $8 price target.
01/25/17
SBSH
01/25/17
NO CHANGE
Target $94
SBSH
Buy
DISH removed from Focus List at Citi
Citi analyst Jason Bazinet removed DISH Network (DISH) from his firm's Focus List but keeps a Buy rating on the shares with a $94 price target. Under a Trump administration, Verizon (VZ) may have more options to acquire spectrum outside of acquiring DISH, Bazinet tells investors in a research note. Divestitures from a potential Sprint (S), T-Mobile (TMUS) merger could allow Verizon to acquire spectrum, the analyst contends.
T AT&T
$41.48

0.23 (0.56%)

02/14/17
CHLM
02/14/17
NO CHANGE
Target $28
CHLM
Buy
RingCentral should be bought on a pullback, says Craig-Hallum
Craig-Hallum analyst George Sutton says that a "well-orchestrated strategy" of expanding up-market has RingCentral (RNG) positioned to penetrate a massive enterprise opportunity, with 49% of bookings coming from mid-market/enterprise customers. The analyst sees the pullback in the stock as an attractive buying opportunity as he believes it is reacting to cautious commentary surrounding the AT&T (T) relationship and the reversion back to a direct hardware sales model. Sutton notes the direct sales model has no bearing on software revenue, and believes the "impressive" guidance should more than offset any fears surrounding AT&T. He reiterates a Buy rating and $28 price target on RingCentral's shares.
02/14/17
BARD
02/14/17
NO CHANGE
Target $29
BARD
Outperform
RingCentral weakness a buying opportunity, says Baird
Baird analyst William Power said RingCentral (RNG) reported solid Q4 results and guidance above his previous estimates. He noted the stock was down after-hours on a combination of in-line profitability, a hardware accounting change that impacts gross margins, and conservative AT&T (T) comments. Power would use the weakness as a buying opportunity and reiterated his Outperform rating and $29 price target on RingCentral shares.
01/30/17
EVER
01/30/17
INITIATION
Target $44
EVER
Hold
AT&T initiated with a Hold at Evercore ISI
Evercore ISI analyst Vijay Jayant started AT&T with a Hold rating $44 price target.
TMUS T-Mobile
$63.92

3.31 (5.46%)

02/07/17
NOMU
02/07/17
NO CHANGE
Target $62
NOMU
Neutral
T-Mobile price target raised to $62 from $46 at Nomura
Nomura analyst Jeffrey Kvaal raised Neutral rated T-Mobile's price target to $62 from $46 following the release of preliminary Q4 subscriber metrics marked by improved visibility and sustained net add trajectory. Kvaal believes the incumbents remain unwilling to sacrifice margin to compete with the success of unlimited data plans. He assigned a modest premium to a potential M&A scenario, as he is less optimistic than most observers.
02/15/17
RBCM
02/15/17
NO CHANGE
RBCM
T-Mobile 2017 guidance "conservative," says RBC Capital
RBC Capital analyst Jonathan Atkin says that T-Mobile reported "solid" Q4 results. He thinks that the company's 2017 guidance is "conservative" and could rise throughout the year. Atkin keeps an Outperform rating on the stock.
02/15/17
JEFF
02/15/17
NO CHANGE
Target $71
JEFF
Buy
T-Mobile price target raised to $71 from $59 at Jefferies
Jefferies analyst Mike McCormack raised his price target for T-Mobile to $71 saying the company's strong growth is set to continue following its Q4 results. The analyst expects both the net adds and cash EBITDA outlooks for 2017 to move higher. He sees, however, M&A speculation dictating near term share performance. McCormack removed T-Mobile from his firm's Franchise Pick list but keeps a Buy rating on the name.
UNH UnitedHealth
$157.62

-6.03 (-3.68%)

02/06/17
CANT
02/06/17
INITIATION
Target $200
CANT
Overweight
UnitedHealth initiated with an Overweight at Cantor
Cantor analyst Steven Halper initiated UnitedHealth with an Overweight and a $200 price target.
02/17/17
WELS
02/17/17
NO CHANGE
WELS
Outperform
UnitedHealth could face larger fines with DOJ involved, says Wells Fargo
Wells Fargo analyst Peter Costa notes that a whistle blower lawsuit against UnitedHealth focusing on Medicare Advantage and the way members are coded for risk has been unsealed and that the Justice Department has joined some of the claims. The presence of the Justice Department could result in a larger fines and damages than the typical risk score resolutions, Costa tells investors in a research note. A false claims act lawsuit carries potential treble damage penalties, the analyst points out. Costa adds that UnitedHealth stated it will contend the claims vigorously and that the company believes it has complied with the program's rules. The analyst has an Outperform rating on UnitedHealth. The stock is down 3% to $158.01 in pre-market trading.
02/07/17
02/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Target (TGT) and Dollar General (DG) were initiated with an Outperform at Bernstein, while Lowe's (LOW) was initiated with an Underperform. The firm also initiated Costco (COST), Home Depot (HD), and Wal-Mart (WMT) with a Market Perform. 2. Aetna (AET) and UnitedHealth (UNH) were assumed with an Overweight at Cantor. 3. Philips (PHG) initiated with a Hold at Berenberg. 4. Costamare (CMRE) initiated with a Neutral at Citi. 5. BioMarin (BMRN) initiated with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/07/17
CANT
02/07/17
NO CHANGE
Target $200
CANT
UnitedHealth transferred with a Buy at Cantor
Cantor Fitzgerald analyst Steven Halper assumed coverage of UnitedHealth with a Buy rating and $200 price target.
AET Aetna
$125.27

-4.22 (-3.26%)

02/15/17
FBCO
02/15/17
NO CHANGE
Target $220
FBCO
Outperform
Humana price target raised to $220 from $208 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Humana (HUM) to $220 from $208 following the termination of the company's proposed merger with Aetna (AET). The analyst believes Humana offers investors some "new sweets" post "Valentine's Day Break-up," including 2017 EPS guidance above the Street view, an increase in its dividend, a new share buyback, and a full exit from its beleaguered public exchange business in 2018. The analyst reiterates an Outperform rating on Humana's shares.
02/09/17
LEER
02/09/17
NO CHANGE
Target $170
LEER
Outperform
WellCare price target raised to $170 from $160 at Leerink
Leerink analyst Ana Gupte raised her price target for WellCare (WCG) to $170 from $160 following the company's "strong" EPS beat in Q4. The analyst believes WellCare is largely insulated from the downside of the Affordable Care Act "Repeal and Replace" given it had no exposure to Public Exchanges, while its exposure to Medicaid expansion is limited. Gupte sees a takeout as likely, with Aetna (AET) as the most likely buyer followed by Cigna (CI) or Anthem (ANTM). She reiterates an Outperform rating on WellCare's shares.
02/15/17
PIPR
02/15/17
NO CHANGE
Target $231
PIPR
Overweight
Deal termination positive for Humana, says Piper Jaffray
Piper Jaffray analyst Sarah James believes Humana (HUM) is in a stronger position today than when Aetna (AET) announced its merger offer. The analyst views the deal termination as a positive since she feels Humana is more valuable than the merger price. James keeps an Overweight rating on the shares with a $231 price target.
HUM Humana
$204.60

-4.14 (-1.98%)

02/09/17
JPMS
02/09/17
NO CHANGE
JPMS
JPMorgan doesn't expect big moves for Anthem, Cigna shares
Given the low perceived probability of a merger approval, shares of Anthem (ANTM) and Cigna (CI) are unlikely to move materially today, JPMorgan analyst Gary Taylor tells investors in a research note. He also sees "little plausible grounds" for the companies to appeal the court's decision. The merger agreement states that Anthem owes Cigna a $1.85B taxable breakup fee upon a regulatory block, which this judgment clearly represents, Taylor contends. The analyst continues to believe that Anthem and Cigna could have potential interest in acquiring Humana (HUM).
02/07/17
CANT
02/07/17
NO CHANGE
Target $186
CANT
Neutral
Humana transferred with a Neutral at Cantor
Cantor Fitzgerald analyst Steven Halper assumed coverage of Humana with a Neutral rating and $186 price target.
CI Cigna
$143.56

-1.77 (-1.22%)

02/10/17
02/10/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ford (F) upgraded to Hold from Underperform at Jefferies with analyst Philippe Houchois upgraded Ford (F) Motor to Hold saying the company's "bad news" in the last six months has been sufficiently priced into the shares. While cyclical risks remain, Ford should benefit the most of the big three from infrastructure spending, border adjusted tax reform and exposure to a Russian auto recovery, Houchois tells investors in a research note. He raised his price target for the shares to $12 from $10. 2. CSX (CSX) upgraded to Outperform from Market Perform at Avondale. 3. Jack in the Box (JACK) upgraded to Buy from Hold at SunTrust with analyst Jake Bartlett saying he expects the company to benefit from fewer discounts in the sector and market share gains going forward. 4. Cigna (CI) upgraded to Outperform from Sector Perform at RBC Capital with analyst Frank Morgan saying the company is well positioned as a standalone entity. The analyst believes Cigna has "multiple positive levers" to drive earnings higher and sees a likelihood for "significant" capital deployment. Morgan raised his price target for the shares to $172 from $151. 5. Enerplus (ERF) upgraded to Outperform from Market Perform at BMO Capital with analyst Ray Kwan citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/10/17
RBCM
02/10/17
UPGRADE
Target $172
RBCM
Outperform
Cigna upgraded to Outperform from Sector Perform at RBC Capital
RBC Capital analyst Frank Morgan upgraded Cigna to Outperform saying the company is well positioned as a standalone entity. The analyst believes Cigna has "multiple positive levers" to drive earnings higher and sees a likelihood for "significant" capital deployment. Morgan raised his price target for the shares to $172 from $151.
02/15/17
OPCO
02/15/17
NO CHANGE
OPCO
Outperform
Cigna, Anthem deal termination not surprising, says Oppenheimer
Oppenheimer analyst Michael Wiederhorn does not believe there is much of a surprise with Cigna (CI)/Anthem (ANTM) deal officially being terminated, as the recent ruling was likely the final straw. However, the analyst notes that both companies are clearly posturing over the $1.85B termination fee, in what is likely to be an "intense legal battle." Regardless of the outcome, Wiederhorn reiterates an Outperform rating on Cigna due to its robust capital position and attractive valuation, but continues to favor the insurers overall as he thinks the group is well positioned for 2017 and beyond.
ANTM Anthem
$160.25

-3.52 (-2.15%)

02/09/17
SBSH
02/09/17
NO CHANGE
SBSH
Buy
Citi says Anthem, Cigna standalone stories remain attractive
After a federal judge officially blocked the merger between Anthem (ANTM) and Cigna (CI), Citi analyst Ralph Giacobbe says the standalone story of both companies remains attractive. The decision has been anticipated by the market with the only real deal-related question at this point likely around the breakup fee, Giacobbe tells investors in a research note. He views the removal of the deal overhang favorably. Anthem is likely to target a buyback more aggressively while Cigna may take a more measured approach, the analyst contends. He keeps a Buy rating on both names.
YHOO Tag AABA
$45.10

-0.06 (-0.13%)

01/24/17
RBCM
01/24/17
NO CHANGE
RBCM
Yahoo results increase probability of deal closing, says RBC Capital
RBC Capital analyst Mark Mahaney says that Yahoo's (YHOO) "improved" Q4 results increase the chances that Verizon (VZ) will close on its acquisition of the Internet conglomerate. However, Mahaney keeps a Sector Perform rating on Yahoo.
01/05/17
RHCO
01/05/17
NO CHANGE
RHCO
Verizon likely to proceed with Yahoo acquisition, says SunTrust
After Bloomberg reported that Verizon (VZ) was seeking a $5.5B loan, SunTrust analyst Kunal Madhukar says that, assuming the report is accurate, the loan would probably be used to finance Verizon's takeover of Yahoo's (YHOO) core business. The analyst says that if the report is accurate, the deal will probably proceed. Madhukar keeps a Hold rating on Yahoo.
10/28/16
OPCO
10/28/16
NO CHANGE
Target $1000
OPCO
Outperform
Alphabet price target raised to $1000 from $970 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Alphabet (GOOG) to $1000 from $970 following "strong" Q3 results. The analyst believes Alphabet continues to benefit from the same trends, namely demand for mobile clicks driven by improved ad formats, YouTube ads and shift to programmatic. Further, he sees Google Cloud as the fastest growing unit, and expects increased investor focus in 2017. Meanwhile, Helfstein sees no material signs of share loss to Facebook (FB), with Alphabet gaining from Yahoo (YHOO)/Microsoft (MSFT) and other search players. The analyst reiterates an Outperform rating on Alphabet's shares.
01/24/17
OPCO
01/24/17
NO CHANGE
Target $52
OPCO
Outperform
Yahoo sale will be completed despite hacking disclosure, says Oppenheimer
Following Q4 results, Oppenheimer analyst Jason Helfstein notes that Yahoo (YHOO) pushed back the closing of the core sale to Verizon (VZ) from Q1 to Q2, citing "work required to meet closing conditions." The analyst believes that the sale will be completed regardless of Yahoo's most recent hacking disclosure, as it provided engagement data showing minimal impact and since Verizon needs its content scale to create a profitable ad tech stack, if they are going to build a competitive "third stack" to help publishers compete with Facebook (FB) and Google (GOOG; GOOGL). He reiterated an Outperform on Yahoo's stock but lowered his price target on the shares to $52 from $54 to reflect movements in the share prices of Alibaba (BABA) and Yahoo Japan.
VLKAY Volkswagen
$30.87

-0.65 (-2.06%)

02/13/17
RAJA
02/13/17
NO CHANGE
RAJA
Outperform
Mobileye deal with VW has longer-term value, says Raymond James
Raymond James analyst Tavis McCourt noted that Volkswagen's (VLKAY) partnership with Mobileye (MBLY) to use REM technology in its autonomous vehicles was announced back in early 2016, but only finalized today. While the pact has "no meaningful influence" near-term, it does have longer-term financial and strategic value for Mobileye, said McCourt, who keeps an Outperform rating on the shares.
02/13/17
WELS
02/13/17
NO CHANGE
WELS
Outperform
Mobileye could add to competitive advantage with VW deal, says Wells Fargo
Wells Fargo analyst Richard Kwas said that while Volkswagen (VLKAY) was expected to be announced as a customer of Mobileye's (MBLY) Road Experience Management system, the confirmation of an agreement, along with the timeline and language of the agreement, are positive. If the tie-up goes well, REM could set an industry standard and further build on Mobileye's competitive moat, Kwas tells investors. He keeps an Outperform rating on Mobileye shares, which are up 7.25% in afternoon trading.
01/30/17
RBCM
01/30/17
NO CHANGE
RBCM
Auto executives say Trump policies to be a 'net positive,' says RBC Capital
RBC Capital analyst Joseph Spak says that auto executives, after speaking with Trump administration officials, predict that the administration's policies will be "net positive" for auto OEMs. Spak says that "pretty much" every company with whom he spoke says that the risk from the policies will be "manageable," The analyst adds that executives who met with administration officials expect " rationality on some of the extreme measures will prevail," while measures such as a reduced corporate tax and less regulation will provide "offsets." Publicly traded companies in the space include Daimler AG (DDAIF), Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Toyota (TM) and Volkswagen (VLKAY).
02/13/17
JEFF
02/13/17
NO CHANGE
Target $52
JEFF
Buy
Jefferies says Mobileye agreement not unexpected, but important
Mobileye's (MBLY) agreement with Volkswagen (VLKAY) is not expected given the previously disclosed memorandum of understanding, but it is important nonetheless, Jefferies analyst David Kelley tells investors in a research note. The deal substantiates Mobileye's "strong" early positioning" in the integral segment of the "rapidly developing" autonomous vehicle sector, the analyst contends. He keeps a Buy rating on the shares with a $52 price target.
MBLY Mobileye
$45.65

0.68 (1.51%)

02/01/17
SBSH
02/01/17
NO CHANGE
Target $66
SBSH
Buy
Citi positive on Mobileye after Morgan Stanley downgrade
Citi analyst Itay Michaeli, in an intraday research note, detailed why he thinks Mobileye's competitive position is actually strengthening. The stock is down 35c to $42.61 after Morgan Stanley's Adam Jonas downgraded his rating on the shares this morning to Equal Weight from Overweight. Michaeli told investors that he's not aware of any current in-production Advanced Driver Assistance Systems/semi-autonomous features today that "display superior vision features" to Mobileye's. He notes that the company disclosed at this year's Consumer Electronics Show, to little fanfare, that throughout 2016 it won 12 programs covering 47 vehicle models across 11 car manufacturers. Itay has a Buy rating on Mobileye with a $66 price target.
CC Chemours
$33.06

1.16 (3.64%)

02/17/17
SUSQ
02/17/17
UPGRADE
Target $40
SUSQ
Positive
Chemours upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Don Carson upgraded Chemours to Positive from Neutral citing significant upside he sees to management's modest EBITDA guidance due to greater momentum in TiO2 prices. He noted the prices are at the beginning of a multi-year cyclical rebound, while there will be continued structural cost reductions, faster adoption of Opteon refrigerant, and reduced litigation risk. Carson raised his price target to $40 from $26 on Chemours shares.
02/17/17
02/17/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Workday (WDAY) upgraded to Overweight from Neutral at Piper Jaffray by analyst Alex Zukin, who said his channel checks indicate the company's fundamentals have improved materially since last quarter. He notes that his checks on Workday and Salesforce (CRM) "came back the strongest in recent memory." 2. Tempur Sealy (TPX) upgraded to Outperform from Market Perform at Raymond James, as analyst Budd Bugatch said all the bad news is known and the improvement in revenues and earnings will become more visible as 2017 unfolds. 3. Capital One (COF) upgraded to Buy from Neutral at Goldman Sachs by analyst Ryan Nash, who raised his price target for the shares to $110 from $106. Almost all of the bank's increases in losses during 2016 can be explained by "growth math," which should have a "finite life to it," Nash tells investors. 4. Credit Suisse (CS) upgraded to Overweight from Equal Weight at Morgan Stanley by analyst Magdalena Stoklosa, who thinks connectivity across businesses, capital utilization, and earnings quality from here will result in more predictable earnings. 5. Chemours (CC) upgraded to Positive at Susquehanna by analyst Don Carson, who sees significant upside he sees to management's modest EBITDA guidance due to greater momentum in TiO2 prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/13/17
GSCO
02/13/17
UPGRADE
Target $40
GSCO
Buy
Goldman upgrades Chemours to Buy following legal settlement
Goldman Sachs analyst Robert Koort upgraded Chemours to Buy from Neutral saying the PFOA multi-district litigation settlement "removes a meaningful overhang" on the shares. The resolution should expand "dramatically" the potential investor base that may have been interested in playing a recovering TiO2 market, Koort tells investors in a research note. He views Chemours as "clear industry leader" and upped his price target for the shares to $40 from $27. The stock in afternoon trading is up 14%, or $3.92, to $32.05.
02/17/17
SUSQ
02/17/17
UPGRADE
SUSQ
Positive
Chemours upgraded to Positive from Neutral at Susquehanna
DD Changed to DWDP
$77.49

-0.3 (-0.39%)

01/25/17
FBCO
01/25/17
NO CHANGE
Target $76
FBCO
Neutral
DuPont price target raised to $76 from $70 at Credit Suisse
Credit Suisse analyst Christopher Parkinson raised his price target for DuPont to $76 from $70 following Q4 results, citing "solid execution" in a difficult macro environment. The analyst reiterates a Neutral rating on the shares.
02/08/17
BOFA
02/08/17
NO CHANGE
Target $90
BOFA
DuPont price target raised to $90 from $82 at BofA/Merrill
BofA/Merrill analyst Steve Byrne raised DuPont's (DD) price target to $90 from $82 and Dow Chemical's to (DOW) $70 from $64 on increased probability the merger will be completed following comments from the EU's Competition Commissioner Vestager. DuPont remains Byrne's top pick in the sector due to significant synergies from the pending merger.
01/30/17
ARGS
01/30/17
DOWNGRADE
ARGS
Hold
DuPont downgraded to Hold from Buy at Argus
Argus analyst Bill Selesky downgraded DuPont to Hold following the strong run-up in shares and is now approaching his former price target of $80.
01/06/17
JPMS
01/06/17
NO CHANGE
Target $128
JPMS
Overweight
Monsanto shares are mispriced, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas says Monsanto (MON) shares are mispriced and offer an attractive risk/reward proposition. A first catalyst for the shares would be regulatory agreement in the Dow Chemical (DOW)/DuPont (DD) transaction, Zekauskas tells investors in a research note. The analyst thinks a favorable resolution to the Dow/DuPont merger would be seen as improving the probability of the success of the Bayer/Monsanto transaction. He notes that Bayer has agreed to purchase Monsanto for $128 per share in cash, which represents 21% appreciation potential should the deal close by year-end. Zekauskas thinks a "reasonable floor" price for Monsanto shares, should the deal fail, is $102. He keeps an Overweight rating on the name with a $128 price target.
HAIN Hain Celestial
$34.95

0.49 (1.42%)

02/17/17
ARGS
02/17/17
DOWNGRADE
ARGS
Hold
Hain Celestial downgraded to Hold from Buy at Argus
Argus analyst John Staszak downgraded Hain after the company announced that it was being probed by the SEC. Staszak says that, at a minimum, Hain will have to restate its financials.
02/17/17
JEFF
02/17/17
NO CHANGE
Target $50
JEFF
Buy
Jefferies more confident in Hain's growth after portfolio review
After analyzing the company's U.S. portfolio, Jefferies analyst Akshay Jagdale has increased confidence in his growth thesis for Hain Celestial. He has a Buy rating on the shares with a $50 price target. The company's market share has stabilized and is poised to expand, Jagdale tells investors in a research note. He believes Hain's categories can grow mid- to high-single-digits per year.
02/13/17
JEFF
02/13/17
NO CHANGE
Target $50
JEFF
Buy
Hain Celestial accounting review likely immaterial, says Jefferies
Jefferies analyst Akshay Jagdale says Hain Celestial revealed two new pieces of information post the market close on Friday: an SEC investigation and expansion in the scope of its accounting review. The analyst continues to expect the accounting review to result in a non-material impact on earnings. No material findings have been disclosed in any of Hain's correspondence since the review began 6-9 months ago and the board has completed an independent review that found no evidence of wrongdoing, Jagdale tells investors in a research note. He estimates a $30 share price in the worst case and $50 per share price in the best case. Jagdale sees upside in the name and keeps a Buy rating on Hain with a $50 price target.
02/17/17
02/17/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hertz (HTZ) downgraded to Underperform from Neutral at Credit Suisse by analyst Anjaneya Singh as the analyst believes peer Avis Budget's (CAR) update presents a negative read-through for Hertz's Q4 and 2017 guidance. In an environment that presents weak volume growth, flattish pricing, and inflationary fleet costs, Singh sees Hertz struggling to generate profit growth reflected in consensus estimates. The firm also downgraded Avis Budget to Neutral from Outperform following the company's Q4 results. 2. Charter (CHTR) downgraded to Market Perform after recent rally at Telsey Advisory by analyst Tom Eagan, who has "no doubt" that the company will improve the service metrics at the legacy TWC and Bright House systems, but notes that shares have gained more than 54% since January 2016, with part of the rise fueled by speculation that Verizon (VZ) was interested in an acquisition. While unclear what Verizon's real interest is, "the possibility of a transaction is not grounds" for a multiple on Charter shares that would yield a target in the mid-$370's, Eagen tells investors. 3. Kate Spade (KATE) downgraded to Underperform from Outperform at CLSA by analyst Rick Patel, who benchmarks Kate with Tumi, which was acquired by Samsonite for 13.6x LTM EBITDA. He adds that he views the abbreviated conference call and lack of Q&A as signs the company is "actively in negotiations." 4. Advisory Board (ABCO) downgraded to Neutral from Overweight at JPMorgan by analyst Stephanie Davis, who sees the shares as fairly valued for the potential strategic alternative outcomes. The analyst sees three potential outcomes: a margin-focused restructuring, a sale to a strategic acquirer of all or part of the company, and a sale to a financial sponsor. Her analysis yields a share price range of $47-$59 for the three scenarios. 5. Hain Celestial (HAIN) downgraded to Hold from Buy at Argus by analyst John Staszak, who says that, at a minimum, Hain will have to restate its financials. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
KATE Kate Spade
$23.19

0.63 (2.79%)

02/16/17
WBLR
02/16/17
NO CHANGE
WBLR
Outperform
William Blair says $21-$29 per share 'reasonable assumption' for Kate Spade deal
William Blair analyst Dylan Carden said Kate Spade's better performance in Q4 provides potential upside to an expected takeout price and continues to see 10-14 times trailing EBITDA as "a reasonable assumption" for a potential sale. That multiple suggests a deal price of $21 to $29 per share based on 2016 EBITDA of $261M, noted Carden, who keeps an Outperform rating on Kate Spade shares.
02/17/17
KEYB
02/17/17
NO CHANGE
KEYB
Kate Spade could be acquired by Coach, says KeyBanc
KeyBanc says that Coach (COH) "could make a compelling buyer" of Kate Spade (KATE), as Coach or another strategic buyer could obtain significant value from the transaction, according to the firm. The firm thinks that an acquisition of Kate Spade would raise Coach's EPS by 60c+ in the first 24 months of an acquisition, and it believes that Kate Spade could be acquired for a price in the mid-$20s per share range. KeyBanc keeps an Overweight rating on Kate Spade.
02/17/17
LYON
02/17/17
DOWNGRADE
Target $23
LYON
Underperform
Kate Spade downgraded to Underperform from Outperform at CLSA
CLSA analyst Rick Patel raised his price target on Kate Spade to $23 from $21 but downgraded the stock to Underperform from Outperform, stating that he benchmarks Kate with Tumi, which was acquired by Samsonite for 13.6x LTM EBITDA. He adds that he views the abbreviated conference call and lack of Q&A as signs the company is "actively in negotiations."
AGN Allergan
$247.35

0.42 (0.17%)

02/16/17
JPMS
02/16/17
INITIATION
Target $56.5
JPMS
Neutral
ZELTIQ reinstated with a Neutral at JPMorgan
JPMorgan analyst Tycho Peterson reinstated ZELTIQ Aesthetics (ZLTQ) with a Neutral rating and $56.50 price target following a period of restriction. The analyst does not expect a competing takeover bid to Allergan's (AGN) to emerge, especially with Hologic (HOLX) recently acquiring Cynosure (CYNO).
02/14/17
RBCM
02/14/17
NO CHANGE
RBCM
Allergan deal creates significant opportunities, says RBC Capital
RBC Capital analyst Randall Stanicky says that Allergan's (AGN) acquisition of ZELTIQ (ZLTQ) is "expensive," but creates significant opportunities for Allergan, including "broad coverage" of the "heavily under-penetrated" aesthetics market and the ability to cross-sell to its current aesthetics customers. The analyst keeps a $279 price target and an Outperform rating on Allergan.
02/17/17
WBLR
02/17/17
NO CHANGE
WBLR
Outperform
William Blair estimates $102/share buyout value for SAGE
After SAGE Therapeutics (SAGE) CEO Jeff Jonas noted during an interview yesterday that his company has received takeover interest, William Blair analyst Tim Lugo made some estimates on what SAGE could garner in a takeout scenario. An acquisition is unlikely before the Phase III studies set to report out through midyear as well as several other proof-of-concept studies, Lugo cautions. He believes, however, that the company's "strong pipeline of central nervous system targeting therapies" would be complementary to a number of larger companies, including Allergan (AGN), AstraZeneca (AZN) and potentially Biogen (BIIB). When using comparable acquisitions of companies in the pre-commercial phase with a median premium of 55% to the prior close and a 2.8 times enterprise value to his peak sales estimate of $1.5B, Lugo arrives at potential takeover value for SAGE of $102 per share, or a $4.2B enterprise value. Using a sum-of-the-parts analysis, the analyst arrives at a fair-value estimate between $95 and $100 per share. SAGE in early trading is down $2.36 to $60.39. Lugo has an Outperform rating on the stock.
02/13/17
LEER
02/13/17
NO CHANGE
LEER
ZELTIQ takeover raises M&A chances for other aesthetic players, says Leerink
After Allergan (AGN) announced an agreement to acquire ZELTIQ Aesthetics (ZLTQ) for $2.475B, Leerink analyst Richard Newitter said he thinks the deal increases the takeover prospects for other aesthetic players, particularly those with non-invasive fat offerings. With ZELTIQ off the table, Cynosure (CYNO), Syneron Medical (ELOS) and Cutera (CUTR) could "move into play for another strategic acquirer relatively quickly," Newitter tells investors. The analyst adds that he views Cynosure as "a much higher quality asset" than Syneron, but adds that the latter is "significantly cheaper." On ZELTIQ, he thinks Allergan is "likely the final suitor" given the price it has agreed to pay.
ZLTQ ZELTIQ
$55.67

-0.02 (-0.04%)

02/13/17
MAXM
02/13/17
DOWNGRADE
MAXM
Hold
ZELTIQ downgraded to Hold from Buy at Maxim
Maxim downgraded ZELTIQ (ZLTQ) to Hold from Buy, citing the company's deal to be acquired by Allergan (AGN). ZELTIQ shares were also downgraded at William Blair, Canaccord and Piper Jaffray.
02/15/17
NRCS
02/15/17
DOWNGRADE
NRCS
Neutral
ZELTIQ downgraded to Neutral from Buy at Northcoast
Allergan (AGN) announced an agreement to acquire ZELTIQ Aesthetics (ZLTQ) for $2.475B, or $56.50 per share.
QSR Restaurant Brands
$53.90

0.05 (0.09%)

02/14/17
COWN
02/14/17
NO CHANGE
Target $51
COWN
Market Perform
Restaurant Brands price target raised to $51 from $43 at Cowen
Cowen analyst Andrew Charles raised his price target on Restaurant Brands to $51 from $43 following Q4 results. the analyst cited quicker than expected unit openings, which should continue in 2017 and add to EBITDA. Charles raised his 2017 and 2018 estimates and reiterated his Market Perform rating on Restaurant Brands shares.
02/14/17
MAXM
02/14/17
NO CHANGE
Target $70
MAXM
Hold
Popeyes price target raised to $70 after report of takeover interest at Maxim
After Reuters suggested Restaurant Brands (QSR) approached Popeyes Louisiana Kitchen (PLKI) about a possible acquisition, Maxim analyst Stephen Anderson said he views such a proposed buyout as "plausible," but believes the question investors are likely to ask is if such a deal could be financed. He raised his price target on Popeyes shares to $70 from $63 to reflect the increased potential for a takeover, but keeps a Hold rating on the stock, as he sees limited upside even weighing the potential of an acquisition.
02/14/17
FBCO
02/14/17
NO CHANGE
Target $53
FBCO
Neutral
Restaurant Brands price target raised to $53 from $45 at Credit Suisse
Credit Suisse analyst Jason West raised his price target for Restaurant Brands (QSR) to $53 from $45 following a Reuters report saying the company has approached Popeyes Louisiana Kitchen (PLKI) about a potential acquisition. The analyst believes that aside from the potential cost savings, Restaurant Brands may look to accelerate the pace of store openings at Popeyes, particularly internationally, via the former's existing franchise network and new partnerships. He reiterates a Neutral rating on Restaurant Brands' shares.
02/14/17
UBSW
02/14/17
NO CHANGE
Target $60
UBSW
Buy
Restaurant Brands price target raised to $60 from $55 at UBS
UBS analyst Dennis Geiger raised his price target to $60 from $55 on Restaurant Brands following what he sees as solid Q4 results. The analyst views the company as well positioned for further upside as global Burger King momentum is expected to continue while sales initiatives should spur Tim Horton's growth. Geiger reiterated his Buy rating on Restaurant Brands shares.
PLKI Acquired by QSR
$66.12

-0.26 (-0.39%)

02/14/17
SIDC
02/14/17
DOWNGRADE
SIDC
Neutral
Popeyes downgraded to Neutral from Buy at Sidoti
02/14/17
02/14/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Depomed (DEPO) downgraded to Neutral from Buy at Mizuho, as analyst Irina Koffler said her conviction in a takeout has diminished. Koffler said without a deal there is also potential for management turnover due to activist involvement, which could lead to a decline in shares... 2. Aviragen (AVIR) downgraded to Neutral from Buy at Ladenburg by analyst Kevin DeGeeter after vapendavir failed to demonstrate an improvement in asthma symptoms. The analyst expects the company to discontinue development of vapendavir in asthmatics and re-evaluate plans for a Phase IIb study in hematopoietic stem cell transplant recipients... 3. Taylor Morrison (TMHC) downgraded to Market Perform from Outperform at FBR Capital, with Alex Rygiel citing valuation... 4. Hibbett Sports (HIBB) downgraded to Equal Weight from Overweight at Stephens, to Hold from Buy at SunTrust, and to Neutral from Positive at Susquehanna following a Q4 preannouncement that missed expectations and disappointing guidance... 5. Popeyes (PLKI) downgraded to Neutral from Buy at Sidoti. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HOLX Hologic
$40.00

0.47 (1.19%)

02/15/17
02/15/17
UPGRADE
Target $46

Buy
Hologic upgraded to Buy at Needham
As previously reported, Needham analyst Mike Matson upgraded Hologic (HOLX) to Buy from Hold, with a $46 price target, after the company announced it is acquiring Cynosure (CYNO) for $1.44B with an all-cash tender offer. While he acknowledges the deal surprised him, Matson says it makes sense for Hologic, noting that Cynosure should increase the company's revenue growth and EPS.
02/15/17
ADAM
02/15/17
NO CHANGE
Target $48
ADAM
Buy
Hologic acquisition adds to growth profile and business, says Canaccord
Canaccord analyst Mark Massaro said he did not expect Hologic (HOLX) to make such a big acquisition when it bought Cynosure (CYNO), but he likes the deal and expects it to add to top-line growth. With its recent deals, Hologic swapped out a declining business for a double digit grower, added Massaro, who reiterated his Buy rating and $48 price target on Hologic shares.
02/15/17
02/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fossil (FOSL) downgraded to Underperform from Market Perform at Wells Fargo, with analyst Ike Boruchow saying Q4 sales missed expectations "despite a much hyped push into wearables" while Q1 trends suggest that reorder activity has been "extremely weak following their holiday sell-in." 2. Under Armour (UA) downgraded to Negative from Neutral at Susquehanna, with analyst Sam Posner arguing that 20% annual revenue growth is "a thing of the past for the foreseeable future." Poser tells investors that commentary by CEO Kevin Plank in the current "polarized political climate" make it "nearly impossible" to effectively build a cool urban lifestyle brand, noting that several stars reacted unfavorably to his comments. 3. Hologic (HOLX) downgraded to Neutral from Buy at BofA/Merrill, with analyst Derik de Bruin saying the Cynosure (CYNO) acquisition enhances growth but at lower margins. The analyst said Cynosure adds new higher growth revenue but margins and cash flows are low relative to Hologic's and will not fully offset dilution from the recent blood screening divestiture. 4. Aircastle (AYR) downgraded to Market Perform from Outperform at Cowen by analyst Helane Becker, who said the company's growth rate is slowing as aircraft acquisition is more competitive. Aircastle was also downgraded at FBR Capital to Market Perform from Outperform. 5. Convergys (CVG) downgraded to Hold from Buy at SunTrust by analyst Frank Atkins, who said top line growth may be limited near-term due to increased uncertainty driving weakness in the demand environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here
CYNO Cynosure
$66.25

0.275 (0.42%)

IDTI Integrated Device
$24.42

-0.15 (-0.61%)

02/14/17
CHLM
02/14/17
DOWNGRADE
Target $3.08
CHLM
Hold
GigPeak downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Richard Shannon downgraded GigPeak (GIG) to Hold from Buy after Integrated Device (IDTI) offered to buy the company in an all-cash deal for $3.08 per share. The analyst believes it is very likely the deal will close, although he would not be surprised if some shareholders want to see a higher premium. Shannon also lowered his price target on GigPeak's shares to $3.08 from $3.75.
02/16/17
BOFA
02/16/17
DOWNGRADE
Target $27
BOFA
Neutral
Integrated Device downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Vivek Arya downgraded Integrated Device to Neutral and lowered its price target to $27 from $28 citing limited near-term catalysts. Arya said valuation reflects modest 5% sales and 7% organic earnings CAGR from FY16-19 and sees risk from possible dilution of R&D efforts that pull the company into diverse markets.
01/31/17
CHLM
01/31/17
NO CHANGE
Target $29
CHLM
Buy
Integrated Device price target raised to $29 from $25 at Craig-Hallum
Craig-Hallum analyst Anthony Stoss raised his price target for Integrated Device (IDTI) to $29 from $25 following quarterly results. The analyst notes that the company guided lower due to Samsung (SSNLF) Galaxy S8 pushout, but says he is a buyer on weakness due to DDR4 ramp, WC Going Mainstream and potential as an M&A target. Stoss reiterates a Buy rating on Integrated Device's shares.
02/14/17
LOOP
02/14/17
NO CHANGE
Target $29
LOOP
Buy
Integrated Device acquisition of GigPeak a positive, says Loop Capital
Loop Capital analyst Betsy Van Hees said she was "a little surprised" at the timing of Integrated Device's (IDTI) announcement of its agreement to acquire GigPeak (GIG) for $250M, but she views the pending acquisition as a positive as it alleviates near-term concerns on muted revenue growth. She has a Buy rating and $29 price target on Integrated Device shares.
GIG GigPeak
$3.06

0.01 (0.33%)

10/31/16
NEED
10/31/16
NO CHANGE
NEED
Needham remains bullish on Optical Sector
Needham analyst Alex Henderson believes the "Optical Super Cycle" is going full steam ahead and strongly reiterates his bullish view on the Optical Sector. The analyst believes that most of the angst over the last week around the optical sector is a non-issue. Henderson is an aggressive buyer on weakness of Lumentum (LITE), NeoPhotonics (NPTN), Oclaro (OCLR), and Inphi (IPHI). Finisar (FNSR), Fabrinet (FN), II-VI (IIVI), GigPeak (GIG) and MACOM (MTSI) are also strong recommendations, he added. Further, Henderson believes Acacia Communications (ACIA) has "way overcorrected," and thinks it can rebound on a stronger Q4 outlook and upside to 2017 numbers.
02/14/17
RAJA
02/14/17
DOWNGRADE
RAJA
Market Perform
GigPeak downgraded to Market Perform from Outperform at Raymond James
GigPeak (GIG) is being acquired by Integrated Device Technology (IDTI) for $3.08 per share.
FIG Fortress
$7.99

0.02 (0.25%)

07/11/16
KBWI
07/11/16
DOWNGRADE
KBWI
Market Perform
Fortress downgraded to Market Perform from Outperform at Keefe Bruyette
SFTBF SoftBank
$76.00

0.248 (0.33%)

08/23/16
08/23/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Square (SQ) upgraded to Buy from Hold at Stifel with analyst Scott Devitt saying he now feels more confident in the company's growth and profitability outlook and its competitive position following three quarters of consistent execution. 2. BHP Billiton (BHP) upgraded to Buy from Hold at Jefferies with analyst Christopher LaFemina saying he believes fundamentals have "clearly improved," citing supply that has declined in most cases and demand that has stabilized. 3. SoftBank (SFTBF) upgraded to Overweight from Neutral at JPMorgan with analyst Jun Tanabe citing improved earnings at Sprint (S), the growth in value of its stake in Alibaba (BABA), and the stability of cash flow in its domestic mobile business. 4. Allscripts (MDRX) upgraded to Outperform from Market Perform at Leerink with analyst David Larsen saying he believes that the company's core fundamentals are improving "significantly." 5. Westlake Chemical (WLK) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying that the company's merger with Axiall (AXLL) "creates a new way to play chlor-alkali," as well as synergies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/23/16
JPMS
08/23/16
UPGRADE
JPMS
Overweight
SoftBank upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jun Tanabe upgraded SoftBank (SFTBF) to Overweight from Neutral and raised his price target on the stock to Y9,930 from Y6,500, citing improved earnings at Sprint (S), the growth in value of its stake in Alibaba (BABA), and the stability of cash flow in its domestic mobile business.
12/07/16
OPCO
12/07/16
NO CHANGE
Target $70
OPCO
Outperform
T-Mobile price target raised to $70 from $55 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for T-Mobile (TMUS) to $70 from $55 as he views it as the best way to play the deregulatory/technology driven consolidation. The analyst notes that President-Elect Trump met with Masayoshi Son of SoftBank (SFTBF), who agreed to invest $50B in the U.S. Horan believes the meeting will likely be a precursor to a Sprint (S)/T-Mobile/Dish (DISH) merger to create a discounted quad-play service company. The analyst reiterates an Outperform rating on T-Mobile' shares, and points out that the company has improved its network and taken share from AT&T (T)/Verizon (VZ).
TEVA Teva
$35.20

-0.61 (-1.70%)

02/13/17
WELS
02/13/17
NO CHANGE
WELS
Market Perform
Teva guidance reiteration to help shares, says Wells Fargo
Wells Fargo analyst David Maris thinks Teva's guidance reiteration this morning will likely drive a favorable share reaction to the Q4 results. The analyst notes, however, that the generics business "does not seem as robust" as expected while the Copaxone overhang remains. Maris keeps a Market Perform rating on Teva post this morning's results.
02/10/17
MZHO
02/10/17
DOWNGRADE
MZHO
Underperform
Teva downgraded to Underperform from Neutral at Mizuho
Mizuho analyst Irina Koffler downgraded Teva Pharmaceutical to Underperform with a $27 price target.
02/10/17
02/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) was downgraded to Sell from Hold at Loop Capital, to Sell from Neutral at UBS, to Sell from Neutral at Citi, to Hold from Buy at Deutsche Bank and to Underweight from Neutral at Atlantic Equities. 2. Intel (INTC) downgraded to Hold from Buy at Canaccord with analyst Matthew Ramsay citing management's decision to invest in competitive markets for growth that may prove to mean a prolonged transition and be margin dilutive. Ramsay believes the shares are inexpensive with a strong yield, but the stock may be range bound as margins stagnate. Ramsay lowered his price target to $38 from $43 on Intel shares. 3. Starbucks (SBUX) downgraded to Hold from Buy at Argus with analyst John Staszak saying that it will be difficult for the company to meet its 4%-6% comp sales growth forecast for fiscal 2017. The analyst also worries that "increased spending on new business initiatives and higher compensation costs will weigh on earnings in the near term." 4. Teva (TEVA) downgraded to Underperform from Neutral at Mizuho. 5. Fossil (FOSL) downgraded to Underperform from Neutral at Mizuho with analyst Betty Chen saying she believes Fossil continues to face weak demand for traditional watches in fiscal 2017 and expects gross margins to be pressured by promotions, mix shirt into lower margin off-price channel, and structural headwinds from growing demand for lower-margin smartwatches. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/17/17
JPMS
02/17/17
NO CHANGE
Target $37
JPMS
Neutral
JPMorgan not seeing trapped value to support Teva break-up
After evaluating the standalone profile of Teva's generic and brand businesses, JPMorgan analyst Chris Schott does not see a strong valuation rationale for a break-up of the company. In a research note to investors, Schott says he does not see a "compelling enough profile" within Teva's branded business to support meaningful valuation upside, and he believes a generic multiple re-rating is unlikely in the current environment. The analyst keeps a Neutral rating on Teva with a $37 price target.
CHGG Chegg
$8.04

0.01 (0.12%)

02/23/16
RAJA
02/23/16
DOWNGRADE
RAJA
Market Perform
Chegg downgraded to Market Perform from Outperform at Raymond James
11/08/16
PIPR
11/08/16
NO CHANGE
Target $8.5
PIPR
Overweight
Chegg price target raised to $8.50 from $7 at Piper Jaffray
Piper Jaffray analyst Michael Olson raised his price target for Chegg to $8.50 citing the company's "strong" Q3 results. The company's transition away from physical textbook rentals to an entirely digital revenue base is progressing and could bring a "much more attractive target operating model in '17 and beyond," Olson tells investors in a post-earnings research note. He keeps an Overweight rating on Chegg.
01/09/17
BRRR
01/09/17
NO CHANGE
BRRR
Barrington lays out best stock ideas for 2017
Student Transportation Analysts at Barrington Research laid out their best stock ideas for 2017. In the alphabetical order, the firm's top picks are Chegg (CHGG), Cinemark (CNK), DeVry (DV), Echo Global (ECHO), Gray Television (GTN), Hackett Group (HCKT), Healthways (HWAY), Heritage-Crystal Clean (HCCI), Kadant (KAI), Koppers Holdings (KOP), Primo Water (PRMW), Student Transportation (STB) and WNS Holdings (WNS).
01/12/17
CHLM
01/12/17
NO CHANGE
Target $8
CHLM
Hold
Chegg coverage transitioned with a Hold at Craig-Hallum
Craig-Hallum transitioned coverage of Chegg to Alex Fuhrman with a Hold rating and an $8 price target.
GRPN Groupon
$4.66

0.03 (0.65%)

02/15/17
PIPR
02/15/17
NO CHANGE
Target $6.5
PIPR
Overweight
Piper would own Groupon despite today's 20% rally
Piper Jaffray analyst Samuel Kemp says he'd own shares of Groupon following the company's Q4 results, even with today's 20% post-earnings rally. Groupon's "leaner-and-meaner business is demonstrating its renewed direction," the analyst tells investors in a research note. He sees a "clear path" to EBITDA upside in 2018 and reiterates an Overweight rating on the shares with a $6.50 price target.
02/16/17
WEDB
02/16/17
DOWNGRADE
Target $4.5
WEDB
Neutral
Groupon downgraded to Neutral from Outperform at Wedbush
Wedbush analyst Aaron Turner downgraded Groupon to Neutral following the solid quarter saying shares have achieved his $4.50 price target.
02/16/17
02/16/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Regeneron (REGN) downgraded to Neutral from Buy at Goldman by analyst Terence Flynn, citing valuation with the stock within 9% of his unchanged $417 price target. The analyst sees less upside potential relative to Regeneron's large-cap peers Amgen (AMGN) and Alexion (ALXN), he said. 2. GoDaddy (GDDY) downgraded to Hold from Buy at Summit Redstone by analyst Jonathan Kees, who notes that management brought down growth expectations for its three segments. Kees believes the integration of HEG may be long as personnel need to be trained on GoDaddy products, sales, and service before market expansion begins and believes shares could pullback similar to Web.com (WEB) and Endurance (EIGI) as they went through their acquisitions. 3. Wells Fargo (WFC) downgraded to Neutral at Credit Suisse by analyst Susan Roth Katzke, citing valuation. 4. Angie's List (ANGI) downgraded to Sell from Neutral at Roth Capital by analyst Darren Aftahi, who lowered his price target for the shares to $4.75 from $6.50 following the company's Q4 results. 5. Groupon (GRPN) downgraded to Neutral from Outperform at Wedbush by analyst Aaron Turner, saying shares have achieved his $4.50 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/13/17
WEDB
02/13/17
NO CHANGE
Target $4.5
WEDB
Outperform
Groupon price target lowered to $4.50 from $6.50 at Wedbush
Wedbush analyst Aaron Turner lowered his price target for Groupon to $4.50 saying he's cautious on the stock into the Q4 earnings report on February 15. The company's recovery may not materialize in Q4 due to decelerating site traffic trends, "material" reduction in available Goods inventory and elevated use of order discounts, Turner tells investors in a pre-earnings research note. He keeps an Outperform rating on Groupon, however, saying he still believes the company represents an undervalued turnaround story in the e-commerce space.
WIX Wix.com
$63.85

0.9 (1.43%)

02/15/17
SPHN
02/15/17
NO CHANGE
Target $65
SPHN
Overweight
Wix.com price target raised to $65 from $57 at Stephens
Stephens analyst Samad Samana raised his price target for Wix.com to $65 from $57 after the company closed 2016 with Q4 results that beat consensus revenue, collections, margins and EPS. The analyst reiterates an Overweight rating on the shares.
02/16/17
OPCO
02/16/17
NO CHANGE
Target $70
OPCO
Outperform
Wix.com price target raised to $70 from $54 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Wix.com to $70 from $54 following better Q4 results and guidance. The analyst continues to see Wix.com as the clear leader in web presence/services, serving SMBs globally, through constant dedication to product innovations. He reiterates an Outperform rating on the shares as he is incrementally bullish on the long-term growth opportunity.
02/14/17
JMPS
02/14/17
NO CHANGE
JMPS
Wix.com Q4 results likely to beat expectations, says JMP Securities
JMP Securities analyst Ronald Josey says that the differentiation of Wix.com's new products and services will enable its Q4 results to beat expectations. The analyst identifies the stock as his top small/medium cap pick and reiterates a $57 price target and an Outperform rating on the shares.
11/11/16
JMPS
11/11/16
NO CHANGE
JMPS
Wix.com price target raised to $57 from $42 at JMP Securities
JMP Securities analyst Ronald Josey increased his price target on Wix.com after the company reported better than expected results that he calls "impressive." The analyst thinks that the company's new products will cause its revenue growth to continue to be strong. He reiterates an Outperform rating on the shares.
CSCO Cisco
$33.72

0.12 (0.36%)

02/16/17
UBSW
02/16/17
NO CHANGE
Target $37
UBSW
Buy
Cisco not ruling out any sized deal, says UBS
UBS analyst Steven Milunovich noted Cisco delivered a slight Q2 beat and inline Q3 guidance. The analyst said he sensed urgency in management's tone during the conference call, while the CEO said they are not ruling out any size deal and M&A doesn't depend on cash repatriation. Milunovich maintained his Buy rating and raised his price target to $37 from $35 on Cisco shares.
02/16/17
BERN
02/16/17
NO CHANGE
BERN
Cisco reported 'solid' results, says Bernstein
Bernstein analyst Pierre Ferragu says that Cisco reported "solid" results, and the analyst, noting that Cisco's deferred revenues related to subscriptions rose about 5.1%, says that his thesis on the growth of its subscriptions business is playing out. Ferragu raised his price target on the stock to $37 from $35 and keeps an Outperform rating on the shares.
02/16/17
DBAB
02/16/17
NO CHANGE
Target $40
DBAB
Buy
Cisco price target raised to $40 from $37 at Deutsche Bank
Deutsche Bank analyst Vijay Bhagavath raised his price target for Cisco Systems to $40 saying the company's Q2 results are "better than feared." The analyst reiterates a Buy rating on the shares.
02/16/17
SBSH
02/16/17
NO CHANGE
Target $37
SBSH
Buy
Cisco price target raised to $37 from $34 at Citi
Citi analyst Jim Suva raised his price target for Cisco Systems to $37 citing the company's "solid" Q2 beat and "good" guidance. The analyst expects to see margin expansion as new products ramp in FY17 and Enterprises begin to virtualize more of their hardware. He reiterates a Buy rating on the shares.
NTAP NetApp
$40.17

-0.39 (-0.96%)

02/16/17
UBSW
02/16/17
NO CHANGE
Target $37
UBSW
Sell
NetApp discounting points to underlying weakness, says UBS
UBS analyst Steven Milunovich noted NetApp's top-line results were above consensus and grew for the first time in 13 quarters. Gross margins were lower, probably due to discounting. The analyst said the company's demand has been improving, but the discounting points to underlying weakness. Milunovich raised his estimates and his price target to $37 from $32 but maintained his Sell rating on NetApp shares.
02/16/17
LSCM
02/16/17
UPGRADE
Target $43
LSCM
Buy
NetApp upgraded to Buy from Hold at Lake Street
Lake Street analyst Eric Martinuzzi upgraded NetApp to Buy and raised his price target for the shares to $43 from $32 following the company's Q3 results. William Blair this morning upgraded the shares to Market Perform.
02/16/17
02/16/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. SunPower (SPWR) upgraded to Outperform from Perform by Oppenheimer analyst Colin Rusch, who thinks challenging solar conditions are priced into the shares at current levels. While solar data points "continue to drift modestly lower," the pace of declines has slowed materially, Rusch tells investors, but admits that solar cycle bottoms are difficult to call. 2. ITT (ITT) upgraded to Outperform from Perform at Oppenheimer by analyst Jim Giannakouros, who said momentum in the shares can continue due to increased visibility into the company's earnings power build. 3. MDC Partners (MDCA) upgraded to Buy from Hold at Jefferies by analyst John Janedis, who sees the company's balance sheet as "significantly" de-risked following the $95M investment through the purchase of convertible preferred shares. The analyst, who expects shares to move higher as investors refocus on the business and management executes, raised his price target for the shares to $12 from $4. 4. Argus analyst David Coleman upgraded Hershey (HSY) to Buy from Hold with a $125 price target based on valuation and what he sees as the company's strong 2017 guidance. 5. NetApp (NTAP) upgraded to Buy from Hold at Lake Street. Eric Martinuzzi also raised his price target for the shares to $43 from $32 following the company's Q3 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/16/17
PIPR
02/16/17
NO CHANGE
Target $49
PIPR
Overweight
NetApp shares can continue to move higher, says Piper Jaffray
Piper Jaffray analyst Andrew Nowinski raised his price target for NetApp to $49 from $46 citing the company's "solid" Q3 results and guidance. NetApp appears to have "turned the corner" and is on a path to achieving mid-single digit revenue growth and operating margin of 20%, Nowinski tells investors in a post-earnings research note. He views the valuation as attractive and believes the stock can move higher. Nowinski reiterates an Overweight rating on NetApp.
DE Deere
$110.27

1.1 (1.01%)

01/18/17
OTRG
01/18/17
NO CHANGE
OTRG
North American Farm Equipment sector upgraded to Mixed at OTR Global
OTR Global upgraded the North American Farm Equipment sector to Mixed following positive dealer checks that indicates farm income is better than expected. The firm's analyst now expects 2017 sales to be down 1-4% year-over-year, versus October forecast of down 3-6%.
01/24/17
BREN
01/24/17
INITIATION
Target $90
BREN
Sell
Deere initiated with a Sell at Berenberg
Berenberg analyst Sabastian Juenne initiated Deere with a Sell and a $90 price target. The analyst's 2017 earnings estimate is in-line with consensus but his 2018 earnings forecast is approximately 18% below as he does not expect a meaningful recovery in agricultural equipment spending in North America and Europe in 2018. Juenna said Deere's high exposure to struggling North American and low exposure to resilient markets, could result in a subdued earnings recovery versus more diversified peers.
01/24/17
01/24/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Deere (DE) initiated with a Sell at Berenberg, while the firm initiated AGCO (AGCO) with a Buy. 2. Douglas Dynamics (PLOW) initiated with a Buy at Craig-Hallum. 3. DCP Midstream (DCP) initiated with an Underweight at Morgan Stanley. 4. TechnipFMC (FTI) initiated with a Buy at Goldman. 5. FS Investment (FSIC) initiated with a Neutral at Janney Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/10/17
CLVD
02/10/17
NO CHANGE
CLVD
Deere survey indicates a significant improvement in demand, says Cleveland
Cleveland Research analyst Adam Uhlman said the firm's North American ag equipment dealer survey saw a significant increase in demand with 70% of dealers reporting better than expected Q1 sales. Dealers raised their 2017 sales forecast to down 1% year-over-year from down 8% last quarter, with sentiment largely better. Uhlman raised his FY17 earnings forecast to $5.00 from $4.55 and FY18 to $5.50 from $5.00. The analyst rates Deere a Neutral.
TRUE TrueCar
$14.38

1.13 (8.53%)

02/06/17
RBCM
02/06/17
UPGRADE
RBCM
Outperform
TrueCar upgraded on positive catalysts at RBC Capital
As noted earlier, RBC Capital upgraded TrueCar to Outperform from Sector Perform. Analyst Mark Mahaney expects the company to perform significantly better than expected going forward. The positive catalysts cited by the analyst are an acceleration of the company's partnerships, improved relations with dealers, enhanced marketing efforts, a large total market opportunity, and continued strong industrywide U.S. car sales. Target to $17 from $12.
02/06/17
RBCM
02/06/17
UPGRADE
RBCM
Outperform
TrueCar upgraded to Outperform from Sector Perform at RBC Capital
02/17/17
CHLM
02/17/17
NO CHANGE
Target $20
CHLM
Buy
TrueCar price target raised to $20 from $14 at Craig-Hallum
Craig-Hallum analyst Steve Dyer raised his price target for TrueCar to $20 from $14 as he continues to see significant value in the shares given Q3 results and the subsequent rise in the stock. The analyst reiterates a Buy rating on the shares.
02/17/17
RBCM
02/17/17
NO CHANGE
RBCM
TrueCar reported 'very solid' Q4 results, says RBC Capital
RBC Capital analyst Mark Mahaney says that TrueCar reported "very strong" Q4 results. The analyst continues to be very bullish on the company's fundamentals, and he keeps an Outperform rating on the shares.
ANET Arista Networks
$119.06

18.89 (18.86%)

02/17/17
COWN
02/17/17
NO CHANGE
Target $123
COWN
Outperform
Arista Networks price target raised to $123 from $86 at Cowen
Cowen analyst Paul Silverstein raised his price target on Arista Networks to $123 from $86 following Q4 results. The analyst cited the company's competitive repositioning and the strength of the data center switching upgrade cycle. Silverstein reiterated his Outperform rating on Arista Networks shares.
02/17/17
BMOC
02/17/17
NO CHANGE
BMOC
Arista Networks reported 'blow out' results, says BMO Capital
BMO Capital analyst Tim Long says that Arista's results beat expectations in every area, and he says that its "momentum..is very strong." Long thinks that the company has multiple upcoming positive catalysts, including partnerships, global expansion, and new products. He raised his price target on the shares to $130 from $110 and keeps an Outperform rating on the stock.
02/17/17
FBCO
02/17/17
NO CHANGE
Target $125
FBCO
Outperform
Arista Networks price target raised to $125 from $110 at Credit Suisse
Credit Suisse analyst Kulbinder Garcha raised his price target for Arista Networks to $125 from $110 after the company delivered "strong results." The analyst says the company has "the best secular growth opportunity" in IT Hardware and Networking, and believes the company has a "unique technological advantage" that allows it to disrupt the oligopolistic networking market. He reiterates an Outperform rating on the shares.
02/17/17
KEYB
02/17/17
NO CHANGE
KEYB
Arista Networks price target raised to $121 from $100 at KeyBanc
KeyBanc increased its price target on Arista after the company delivered beat and raise Q4 results. The firm now has more confidence that the company's EPS can reach $4 this year. It keeps an Overweight rating on the stock.
LNCE Snyder's-Lance
$39.00

-0.34 (-0.86%)

02/15/17
DBAB
02/15/17
INITIATION
Target $43
DBAB
Buy
Snyder's-Lance initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Rob Dickerson started Snyder's-Lance with a Buy rating and $43 price target.
06/09/16
BMOC
06/09/16
UPGRADE
BMOC
Outperform
Snyder's-Lance upgraded to Outperform from Market Perform at BMO Capital
06/09/16
BMOC
06/09/16
UPGRADE
BMOC
Outperform
Snyder's-Lance upgraded at BMO Capital
As noted earlier, BMO Capital upgraded Snyder's Lance to Outperform from Market Perform. The firm thinks that Snyder's Lance will benefit from "attractive sales growth and operating margin expansion opportunities." The firm is upbeat on the company's acquisition of Diamond Foods, and it thinks the stock's valuation is attractive. Target to $40 from $36.
AIG AIG
$62.50

0.23 (0.37%)

01/06/17
FBCO
01/06/17
UPGRADE
Target $75
FBCO
Outperform
AIG upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse upgraded AIG to Outperform from Neutral and increased its price target to $75 from $61. Analyst Ryan Tunis has a more favorable view of the P&C turnaround story and increased appreciation regarding the importance of higher interest rates on returns in Commercial P&C. Tunis believes AIG can earn 9% ROE in 2018 and can sustain that level without further restructuring.
02/16/17
DBAB
02/16/17
NO CHANGE
Target $61
DBAB
Buy
Deutsche Bank cuts estimates for AIG 'considerably'
Deutsche Bank analyst Joshua Shanker does not expect AIG to deliver on its adjusted goal of a 62% loss ratio. Management has lost a lot of credibility around its claims regarding underlying margins given the Q4 results, Shanker tells investors in a post-earnings research note. He cut his 2017 earnings per share estimate to $4.70 from $5.30 and 2018 estimate to $5.85 from $6.45. The analyst dropped his price target for AIG shares to $61 from $64 and keeps a Hold rating on the name.
01/25/17
DBAB
01/25/17
NO CHANGE
Target $64
DBAB
Hold
AIG portfolio transfer 'marginally negative,' says Deutsche Bank
Deutsche Bank analyst Joshua Shanker views AIG's (AIG) reserve transfer to Berkshire Hathaway's National Indemnity as "marginally negative" saying it will reduce future earnings. The move could reduce future reserve volatility, but a significant reduction in that volatility will be captured by a sizable charge for loss reserve deficiencies in Q4, Shanker tells investors in a research note. He's estimating those losses at $3B. The analyst keeps a Hold rating on AIG.
01/23/17
WELS
01/23/17
NO CHANGE
WELS
AIG, Chubb, Arthur J. Gallagher named top non-life picks at Wells Fargo
Wells Fargo says that AIG's (AIG) reserve reinsurance contract with Berkshire,(BRK.A) eliminates the "tail risk on the majority of its U.S. commercial lines business," while moving the focus to its "underlying margins." Wells says that Chubb (CB) will soon demonstrate the earnings power and "strong underlying results" created by its merger. Finally, Wells thinks that Arthur J. Gallagher (AJG) is poised to benefit from the rebounding U.S. economy.
PEP PepsiCo
$108.15

0.03 (0.03%)

01/09/17
LEHM
01/09/17
INITIATION
Target $102
LEHM
Equal Weight
PepsiCo initiated with an Equal Weight at Barclays
Barclays analyst Lauren Lieberman started PepsiCo with an Equal Weight rating and $102 price target.
12/12/16
SOCG
12/12/16
UPGRADE
SOCG
Buy
PepsiCo upgraded to Buy from Hold at Societe Generale
09/29/16
STFL
09/29/16
DOWNGRADE
STFL
Hold
Coca-Cola downgraded following Pepsi results at Stifel
As noted earlier, Stifel analyst Mark Swartzberg downgraded Coca-Cola (KO) to Hold from Buy. The analyst downgraded the stock after Pepsi (PEP) reported better than expected Q3 results. The analyst says that Coca-Cola's and Pepsi's organic EPS growth appears to be similar, but he believes that Pepsi is less vulnerable to foreign exchange fluctuations. Additionally, he believes that Coca Cola European Bottlers (CCE) is a better investment than Coca-Cola because of the large amount of revenue synergies which that Coca Cola European Bottlers has identified.
09/16/16
09/16/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. GoPro (GPRO) initiated with a Buy at BofA/Merrill. 2. JetBlue (JBLU) initiated with an Outperform at Imperial Capital. 3. PepsiCo (PEP), Dr Pepper Snapple (DPS), and Monster Beverage (MNST) were initiated with an Outperform at Credit Suisse, while the firm initiated Boston Beer (SAM) with an Underperform. Credit Suisse also initiated Coca-Cola (KO) and Constellation Brands (STZ) with a Neutral. 4. lululemon (LULU) initiated with a Positive at Susquehanna. 5. Target (TGT) coverage assumed with a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
FOSL Fossil
$20.73

0.49 (2.42%)

02/10/17
02/10/17
DOWNGRADE
Target $19

Underperform
Fossil downgraded to Underperform on topline concerns at Mizuho
As previously reported, Mizuho downgraded Fossil to Underperform from Neutral and lowered its price target to $19 from $25. Analyst Betty Chen believes Fossil continues to face weak demand for traditional watches in FY17 and expects gross margins to be pressured by promotions, mix shirt into lower margin off-price channel, and structural headwinds from growing demand for lower-margin smartwatches.
02/15/17
WELS
02/15/17
DOWNGRADE
WELS
Underperform
Fossil downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Ike Boruchow downgraded Fossil to Underperform saying the Q4 sales missed expectations "despite a much hyped push into wearables" while Q1 trends suggest that reorder activity has been "extremely weak following their holiday sell-in." The analyst cut his price target range for the shares to $13-$14 from $22-$24.
LC LendingClub
$5.63

-0.15 (-2.60%)

01/25/17
MSCO
01/25/17
NO CHANGE
Target $8
MSCO
Overweight
LendingClub on a path towards $8, says Morgan Stanley
Morgan Stanley analyst James Faucette said conversations within the industry indicate that institutional interest in marketplace-originated loans continues to grow at a moderate, sustained, pace and has not been impacted by the steepening yield curve. The analyst said contacts that help individuals invest have not seen a deterioration in reinvestment or retention rates. Faucette expects an uneventful Q4 for LendingClub but is excited regarding the 2017 outlook and said shares are firmly on a path towards his $8 price target. Faucttte rates LendingClub an Overweight.
02/15/17
BTIG
02/15/17
NO CHANGE
BTIG
LendingClub stabilization process continuing, says BTIG
After LendingClub reported higher than expected EBITDA but its Q1 guidance came in below expectations, BTIG analyst Mark Palmer says that the company continues to stabilize. He blames the stock's decline in after-hours trading yesterday on a "sell the news" reaction. Palmer reiterates a $9 price target and a Buy rating on the stock.
11/03/16
11/03/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Transocean (RIG) upgraded to Buy from Hold at Canaccord with analyst Alex Brooks noting the company reported very strong third quarter results due to its cost cutting efforts. 2. U.S. Steel (X) upgraded to Neutral from Underperform at BofA/Merrill and to Neutral from Sell at Clarksons Platou. 3. Targa Resources (TRGP) upgraded to Buy from Hold at Stifel with analyst Selman Akyoi citing what he sees as strong fourth quarter export guidance by the company as the primary reason for the upgrade. 4. LendingClub (LC) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst James Faucette saying LendingClub shares are inexpensive and its recent developments/investor survey indicates a stable outlook. 5. Finish Line (FINL) upgraded to Positive from Neutral at Susquehanna with analyst Sam Poser saying he views reports the company is looking to sell JackRabbit as a positive development and believes the company will benefit greatly from its added focus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/06/16
JANY
12/06/16
INITIATION
Target $6
JANY
Neutral
LendingClub initiated with a Neutral at Janney Capital
Janney analyst John Rowan initiated Lending Club to Neutral with a $6 price target due to valuation.
GNC GNC Holdings
$7.64

-0.08 (-1.04%)

01/19/17
GSCO
01/19/17
DOWNGRADE
GSCO
Sell
GNC Holdings downgraded to Sell from Neutral at Goldman
12/23/16
PIPR
12/23/16
NO CHANGE
Target $7
PIPR
Underweight
GNC Holdings price target lowered to $7 from $11 at Piper Jaffray
Piper Jaffray analyst Sean Naughton lowered his price target for GNC Holdings to $7 saying price reductions and the elimination of the paid membership "represent meaningful earnings risks." The analyst cut his 2017 earnings per share estimate to $1.80, well below the consensus of $2.17. He thinks the company's margin pressure could be greater than the Street currently estimates. Naughton believes GNC's trends likely don't improve soon and that its leverage is concerning. The analyst views the company's first ever Super Bowl ad in February as a "risky marketing decision." He keeps an Underweight rating on GNC.
02/15/17
MACQ
02/15/17
NO CHANGE
Target $20
MACQ
Outperform
GNC Holdings shares pricing in 'draconian' outcomes, says Macquarie
Macquarie analyst Bob Summers said GNC Holdings' Q4 and near-term results will prove challenging but management has made decisions that will significantly increase the company's long-term potential to succeed by simplifying pricing and having consistent in-store and online pricing. The analyst said these efforts will pressure margins, but shares are pricing in "draconian" outcomes with shares trading at just over 4x P/E. Summers expects free cash flow to remain positive, which could be further enhanced by cutting the dividend and notes there are no near-term debt maturities to create credit risk. The analyst said even a "slight bend" in same-store sales trends could produce a dramatic positive outcome and reiterates his Outperform rating and $20 price target on GNC Holdings.
01/19/17
GSCO
01/19/17
DOWNGRADE
GSCO
Sell
GNC Holdings downgraded to Sell on brand re-launch, competition at Goldman
As previously reported, Goldman downgraded GNC Holdings to Sell from Neutral and lowered its price target to $8 from $12. Analyst Stephen Tanal believes GNC's brand re-launch, which it cut prices meaningfully across half of its assortment and ended its Gold Card loyalty program, will weigh on profitability to a much greater degree than consensus estimates reflect. The analyst expects persistent same-store-sales declines to persist given share losses to conventional retailers including grocers, drug stores, warehouse/clubs, as well as online challengers.
MGM MGM Resorts
$26.60

-0.26 (-0.97%)

02/16/17
STFL
02/16/17
NO CHANGE
Target $36
STFL
Buy
MGM Resorts should be bought on weakness, says Stifel
Following MGM Resorts Q4 results, Stifel analyst Steven Wieczynski expects the Strip EBITDA miss to garner the most attention, while the margin softness is likely to validate bearish investors' take that the margin improvement story is losing steam. However, the analyst encourages investors to take advantage of any trading weakness to add to or establish new positions in the name as he believes there was a lot of "noise" in the Q4 results, and in no way views the performance as indicative of a structural change in the MGM Resorts story. He reiterates a Buy rating and $36 price target on the shares.
01/19/17
01/19/17
NO CHANGE

Wells Fargo names top gaming stocks
Wells Fargo named MGM Resorts (MGM), Red Rock Resorts (RRR), and Penn National (PENN) as its top 2017 gaming picks. The firm expects Las Vegas Strip casinos to benefit from strong corporate demand and contends that Penn National's stock does not bake in a U.S. recovery.
02/17/17
STFL
02/17/17
NO CHANGE
STFL
MGM Resorts positive thesis intact, says Stifel
Stifel analyst Steven Wieczynski calls MGM's Q4 results "messy" and a "debacle." However, the analyst says he doesn't see any structural problems with the company, and he continues to believe that the company has several positive catalysts. The analyst trimmed his price target on the shares to $35 from $36 and keeps a Buy rating on the name.
02/06/17
JPMS
02/06/17
NO CHANGE
JPMS
Macau gaming revenue 'very strong' in early February, says JPMorgan
JPMorgan analyst DS Kim said the firm's checks indicated that Macau's gross gaming revenue for the first five days of February is estimated at MOP6.3B, which he calls a "very strong" print "no matter how we look at it." The implied average daily revenue is the second highest Chinese New Year run-rate on record, only after 2014's holiday, Kim tells investors, adding that he believes VIP demand came in particularly strong. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Wynn Resorts (WYNN) and Melco Crown (MPEL).
MOH Molina Healthcare
$48.23

-0.95 (-1.93%)

02/16/17
PIPR
02/16/17
NO CHANGE
Target $60
PIPR
Overweight
Molina Healthcare selloff a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Sarah James recommends using today's post-earnings selloff in shares of Molina Healthcare as a buying opportunity. The analyst believes Molina has a "sound business in a rapidly growing market" and can fix its issues. She lowered her price target for the shares to $60 from $65 and keeps an Overweight rating on the name.
02/16/17
STFL
02/16/17
DOWNGRADE
Target $45
STFL
Hold
Molina Healthcare downgraded to Hold from Buy at Stifel
Stifel analyst Thomas Carroll downgraded Molina Healthcare to Hold and reduced its price target to $45 from $64 following the Q4 miss and guidance "massively" below expectations. Carroll commented the primary pressure came from ACA products which have continued to challenge operations amplified by "clunky" risk reducing programs and lack of risk corridor payments promised by the Federal government that did not materialize.
01/26/17
PIPR
01/26/17
NO CHANGE
Target $67
PIPR
Overweight
Piper views Medicaid managed care names as undervalued
Piper Jaffray analyst Sarah James views the Medicaid focused managed care names she covers, namely Centene (CNC), Molina Healthcare (MOH) and WellCare (WCG), as undervalued. "Rapidly" improving sentiment should drive multiple expansion over the next three months, James tells investors in a research note. She believes Medicaid managed care organizations have the ability to reach 10%-15% revenue growth through new state expansion plans and long-term service and support carve-ins. Centene is her top pick in the space with an Overweight rating and $67 price target.
01/23/17
LEER
01/23/17
NO CHANGE
Target $250
LEER
Outperform
Leerink sees Humana as target again after broken deal
After a judge sided with the Department of Justice in blocking Aetna's (AET) buyout of Humana (HUM), Leerink analyst Ana Gupte believes Humana could become a takeover target. Cigna (CI) is the most likely bidder, followed by Anthem (ANTM), Express Scripts (ESRX) and CVS Health (CVS), Gupte tells investors in a research note. The analyst expects Anthem's buyout of Cigna to also be blocked. After Humana, Gupte sees WellCare (WCG), Molina Healthcare (MOH) and Magellan Health (MGLN) as the most likely publicly traded targets post the deal breaks. She reiterates an Outperform rating on Humana with a standalone price target of $250. The stock is down 97c to $199.56 in afternoon trading.
SJM J.M. Smucker
$135.95

-1.89 (-1.37%)

12/06/16
BOFA
12/06/16
INITIATION
Target $130
BOFA
J.M. Smucker initiated with a Neutral at BofA/Merrill
BofA/Merrill analyst Evan Morris initiated J.M. Smucker with a Neutral and a $130 price target. Morris expects underlying trends to remain soft due to increased competition in key food categories and as pet remains in transition.
12/06/16
12/06/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pandora (P) initiated with a Buy at Aegis. 2. McCormick (MKC) initiated with a Buy at BofA/Merrill. 3. Skechers (SKX) initiated with an Outperform at Wells Fargo. 4. J.M. Smucker (SJM) initiated with a Neutral at BofA/Merrill. 5. Charter (CHTR) initiated with an Outperform at RBC Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/15/17
DBAB
02/15/17
INITIATION
Target $145
DBAB
Hold
J.M. Smucker initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Rob Dickerson started J.M. Smucker with a Hold rating and $145 price target.
CPB Campbell Soup
$58.48

-4.07 (-6.51%)

09/19/16
09/19/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PayPal (PYPL) downgraded to Hold from Buy at Canaccord with analyst Michael Graham saying he expects TPV growth to remain solid driven by Venmo and One Touch, but said these factors are well understood and reflected in estimates. 2. Viacom (VIA, VIAB) downgraded to Hold from Buy at Stifel with analyst Benjamin Mogil saying the stock's valuation is no longer attractive in the wake of the news that the company had decided to table its plans to sell a minority stake in Paramount. 3. Caterpillar (CAT) downgraded to Mixed from Positive at OTR Global with the firm saying third quarter global new heavy equipment orders are down 8%-11% year-over-year on weakness in North American. 4. Western Union (WU) downgraded to Negative from Neutral at Susquehanna with analyst James Friedman saying he is concerned about downside risks given the company's high multiple, increased regulatory scrutiny, and the lack of improvement in its Middle East business. 5. Campbell Soup (CPB) downgraded to Hold from Buy at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/16
ARGS
09/19/16
DOWNGRADE
ARGS
Hold
Campbell Soup downgraded to Hold from Buy at Argus
02/15/17
DBAB
02/15/17
INITIATION
Target $65
DBAB
Hold
Campbell Soup initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Rob Dickerson started Campbell Soup with a Hold rating and $65 price target.

TODAY'S FREE FLY STORIES

OIS

Oil States

$24.68

1.275 (5.45%)

11:52
12/13/17
12/13
11:52
12/13/17
11:52
Recommendations
Oil States analyst commentary  »

Oil States target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BURL

Burlington Stores

$110.92

1.3 (1.19%)

11:50
12/13/17
12/13
11:50
12/13/17
11:50
Options
Burlington draws a bullish option play as shares see strength »

Burlington draws a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BT

BT Group

$18.04

-0.0501 (-0.28%)

11:49
12/13/17
12/13
11:49
12/13/17
11:49
Upgrade
BT Group rating change  »

BT Group upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHT

Universal Health Realty

$75.28

1.705 (2.32%)

11:45
12/13/17
12/13
11:45
12/13/17
11:45
Conference/Events
Universal Health Realty management to meet with Jefferies »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

11:40
12/13/17
12/13
11:40
12/13/17
11:40
General news
Bund/T-note spread widening remains intact »

Bund/T-note spread…

CERN

Cerner

$70.36

0.23 (0.33%)

11:39
12/13/17
12/13
11:39
12/13/17
11:39
Periodicals
VA Secretary says contract with Cerner held up by questions, Politico reports »

Veterans Affairs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CACC

Credit Acceptance

$326.25

3.97 (1.23%)

11:34
12/13/17
12/13
11:34
12/13/17
11:34
Hot Stocks
PlainSite says Credit Acceptance disclosures belie 'deeply flawed' model »

In a "Reality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSGP

CoStar Group

$287.83

-2.67 (-0.92%)

11:33
12/13/17
12/13
11:33
12/13/17
11:33
Conference/Events
CoStar Group management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 15

    Dec

  • 26

    Feb

ROG

Rogers Corporation

$158.59

1.4 (0.89%)

11:30
12/13/17
12/13
11:30
12/13/17
11:30
Conference/Events
Rogers Corporation management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Dec

11:30
12/13/17
12/13
11:30
12/13/17
11:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

ROG

Rogers Corporation

$158.89

1.7 (1.08%)

11:29
12/13/17
12/13
11:29
12/13/17
11:29
Conference/Events
Rogers Corporation management to meet with B. Riley FBR »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Dec

HDP

Hortonworks

$19.76

0.18 (0.92%)

11:25
12/13/17
12/13
11:25
12/13/17
11:25
Conference/Events
Hortonworks management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

  • 26

    Feb

CACC

Credit Acceptance

$326.25

3.97 (1.23%)

11:20
12/13/17
12/13
11:20
12/13/17
11:20
Hot Stocks
Credit Acceptance moves lower following short report from PlainSite »

Shares of Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
12/13/17
12/13
11:17
12/13/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
12/13/17
12/13
11:16
12/13/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$96.15

-3.99 (-3.98%)

11:13
12/13/17
12/13
11:13
12/13/17
11:13
Hot Stocks
Ralph Lauren falls after Bofa/Merrill downgrade cites 'dimming' margin story »

Shares of Ralph Lauren…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$61.58

0.555 (0.91%)

11:10
12/13/17
12/13
11:10
12/13/17
11:10
Hot Stocks
Target: Shipt to continue to run business independently post-acquisition »

Shipt will be a wholly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$63.48

0.41 (0.65%)

, T

AT&T

$37.75

-0.35 (-0.92%)

11:10
12/13/17
12/13
11:10
12/13/17
11:10
Hot Stocks
Cable, telecom stocks dip as T-Mobile plans to bring 'un-carrier' to TV »

T-Mobile (TMUS) is…

TMUS

T-Mobile

$63.48

0.41 (0.65%)

T

AT&T

$37.75

-0.35 (-0.92%)

ROKU

Roku

$46.95

-1.03 (-2.15%)

CMCSA

Comcast

$39.51

1.07 (2.78%)

CMCSK

Comcast

CHTR

Charter

$329.99

-1.5 (-0.45%)

VZ

Verizon

$52.82

-0.375 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

  • 13

    Dec

LITE

Lumentum

$51.75

-1.75 (-3.27%)

, FNSR

Finisar

$19.30

-0.51 (-2.57%)

11:09
12/13/17
12/13
11:09
12/13/17
11:09
Recommendations
Lumentum, Finisar, Apple analyst commentary  »

Apple's investment…

LITE

Lumentum

$51.75

-1.75 (-3.27%)

FNSR

Finisar

$19.30

-0.51 (-2.57%)

AAPL

Apple

$171.70

-0.97 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$185.73

-0.49 (-0.26%)

11:09
12/13/17
12/13
11:09
12/13/17
11:09
Periodicals
Netflix executive fired over Masterson assault comments, Page Six says »

Netflix director of kids…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$61.64

0.62 (1.02%)

11:06
12/13/17
12/13
11:06
12/13/17
11:06
Technical Analysis
Technical View: Target spikes after acquiring Shipt for $550M »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$61.70

0.68 (1.11%)

11:02
12/13/17
12/13
11:02
12/13/17
11:02
Hot Stocks
Breaking Hot Stocks news story on Target »

Target to bring same-day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$61.69

0.67 (1.10%)

11:01
12/13/17
12/13
11:01
12/13/17
11:01
Hot Stocks
Breaking Hot Stocks news story on Target »

Target: Same-day delivery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$61.72

0.71 (1.16%)

11:01
12/13/17
12/13
11:01
12/13/17
11:01
Hot Stocks
Target to buy same-day delivery platform Shipt for $550M in cash »

Target announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AYI

Acuity Brands

$165.44

-8.79 (-5.05%)

10:59
12/13/17
12/13
10:59
12/13/17
10:59
Technical Analysis
Technical View: Acuity Brands tumbles, levels to watch »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 09

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.